PTC Therapeutics, Inc. ( PTCT) - Key Metrics
PTCT Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q1 | ? | ? | ? | ? |
| 2025Q4 | $2.04 | -$1.67 | -$0.42 | -$0.45 |
| 2025Q3 | $2.59 | $0.20 | -$0.81 | -$0.86 |
| 2025Q2 | $2.29 | -$0.83 | -$0.75 | -$0.80 |
| 2025Q1 | $15.06 | $11.09 | $11.14 | $11.11 |
PTCT Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q1 | ? | ? |
| 2025Q4 | ? | -11.35 |
| 2025Q3 | ? | 78.66 |
| 2025Q2 | ? | -14.71 |
| 2025Q1 | ? | 1.15 |
PTCT
Price: $73.88
52 week price:
Earnings Per Share: -2.54 USD
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 588300
Ebitda: -20.6 millionMarket Capitalization: 5.7 billion